Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells - PubMed (original) (raw)
Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells
Dzung H Nguyen et al. J Immunol. 2005.
Abstract
Humans are genetically incapable of producing the mammalian sialic acid N-glycolylneuraminic acid (Neu5Gc), due to an inactivating mutation in the enzyme synthesizing it. Despite this, human cells and tissues appear capable of metabolically incorporating Neu5Gc from exogenous sources, including dietary red meat and dairy products. All normal humans studied are now shown to have circulating Abs against Neu5Gc, with marked differences in isotype levels. The question arises whether such Abs can adversely affect Neu5Gc-expressing human cells or tissues. In this study, we show that although normal human PBMC do not incorporate Neu5Gc during in vitro incubation, activated T cells do. Primary human leukemia cells and human leukemic cell lines are even more efficient at incorporation. Human sera containing naturally high levels of anti-Neu5Gc IgG Abs (hereafter abbreviated GcIg) deposited complement on Neu5Gc-expressing leukemic cells and activated T cells, but not on normal cells. The binding of GcIg resulted in complement-mediated cytotoxicity, which was inhibited by heat inactivation. Low anti-Neu5Gc IgG-containing human sera did not mediate any of these effects. Mixed killing assays confirmed the 15-fold selective killing of leukemic cells over PBMC by GcIg following Neu5Gc feeding. This approach could potentially serve as novel way to target malignant cells for death in vivo using either natural Abs or anti-Neu5Gc Abs prepared for this purpose. Further studies are needed to determine whether deposition of natural GcIg and complement can also target healthy proliferating immune cells for death in vivo following incorporation of dietary Neu5Gc.
Similar articles
- Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid.
Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E. Tangvoranuntakul P, et al. Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12045-50. doi: 10.1073/pnas.2131556100. Epub 2003 Oct 1. Proc Natl Acad Sci U S A. 2003. PMID: 14523234 Free PMC article. - Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.
Bardor M, Nguyen DH, Diaz S, Varki A. Bardor M, et al. J Biol Chem. 2005 Feb 11;280(6):4228-37. doi: 10.1074/jbc.M412040200. Epub 2004 Nov 22. J Biol Chem. 2005. PMID: 15557321 - Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.
Diaz SL, Padler-Karavani V, Ghaderi D, Hurtado-Ziola N, Yu H, Chen X, Brinkman-Van der Linden EC, Varki A, Varki NM. Diaz SL, et al. PLoS One. 2009;4(1):e4241. doi: 10.1371/journal.pone.0004241. Epub 2009 Jan 21. PLoS One. 2009. PMID: 19156207 Free PMC article. - From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
Dhar C, Sasmal A, Varki A. Dhar C, et al. Front Immunol. 2019 Apr 17;10:807. doi: 10.3389/fimmu.2019.00807. eCollection 2019. Front Immunol. 2019. PMID: 31057542 Free PMC article. Review. - Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
Yehuda S, Padler-Karavani V. Yehuda S, et al. Front Immunol. 2020 Jan 23;11:21. doi: 10.3389/fimmu.2020.00021. eCollection 2020. Front Immunol. 2020. PMID: 32038661 Free PMC article. Review.
Cited by
- Knock-out of N-glycolylneuraminic acid attenuates antibody-mediated rejection in xenogenically perfused porcine lungs.
Chaban R, Habibabady Z, Hassanein W, Connolly MR, Burdorf L, Redding E, Laird C, Ranek J, Braileanu G, Sendil S, Cheng X, Sun W, O'Neill NA, Kuravi K, Hurh S, Ayares DL, Azimzadeh AM, Pierson RN 3rd. Chaban R, et al. Xenotransplantation. 2022 Nov;29(6):e12784. doi: 10.1111/xen.12784. Epub 2022 Oct 17. Xenotransplantation. 2022. PMID: 36250568 Free PMC article. - Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.
Padler-Karavani V, Varki A. Padler-Karavani V, et al. Xenotransplantation. 2011 Jan-Feb;18(1):1-5. doi: 10.1111/j.1399-3089.2011.00622.x. Xenotransplantation. 2011. PMID: 21342282 Free PMC article. No abstract available. - In-depth characterization of non-human sialic acid (Neu5Gc) in human serum using label-free ZIC-HILIC/MRM-MS.
Seo N, Ko J, Lee D, Jeong H, Oh MJ, Kim U, Lee DH, Kim J, Choi YJ, An HJ. Seo N, et al. Anal Bioanal Chem. 2021 Aug;413(20):5227-5237. doi: 10.1007/s00216-021-03495-1. Epub 2021 Jul 7. Anal Bioanal Chem. 2021. PMID: 34235565 - Creation of a milk oligosaccharide database, MilkOligoDB, reveals common structural motifs and extensive diversity across mammals.
Durham SD, Wei Z, Lemay DG, Lange MC, Barile D. Durham SD, et al. Sci Rep. 2023 Jun 26;13(1):10345. doi: 10.1038/s41598-023-36866-y. Sci Rep. 2023. PMID: 37365203 Free PMC article. - Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.
Vázquez AM, Hernández AM, Macías A, Montero E, Gómez DE, Alonso DF, Gabri MR, Gómez RE. Vázquez AM, et al. Front Oncol. 2012 Oct 23;2:150. doi: 10.3389/fonc.2012.00150. eCollection 2012. Front Oncol. 2012. PMID: 23110257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources